Olink Holding AB (publ) (OLK) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Uppsala, Sweden. Le PDG actuel est Jon Heimer.
OLK a date d'introduction en bourse 2021-03-26, 707 employés à temps plein, cotée sur le NASDAQ Global Market, une capitalisation boursière de $3.24B.
Olink Holding AB (publ) is a Swedish life sciences company founded in 2004 and headquartered in Uppsala that provides protein analysis products and services to academic institutions, government agencies, and biopharmaceutical and biotechnology companies. The company's platform includes Olink Explore for disease-specific research areas such as cardiovascular, metabolic, oncology, and neurology applications, along with customizable Olink Target and Olink Focus product lines. Olink offers comprehensive solutions spanning assay execution through its Olink Signature Q100 platform, analytical services including study design and data processing, and software tools such as NPX Manager and Olink Insight for data visualization and statistical analysis. The company operates a direct sales organization across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions to serve its global customer base.
